Related references
Note: Only part of the references are listed.Supporting clinical management of the difficult-to-treat TB cases: the ERS-WHO TB Consilium
Lia D'Ambrosio et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Triggering Through Toll-like Receptor 2 Limits Chronically Stimulated T-helper Type 1 Cells From Undergoing Exhaustion
Sathi Babu Chodisetti et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Isoniazid Induces Apoptosis Of Activated CD4+ T Cells IMPLICATIONS FOR POST-THERAPY TUBERCULOSIS REACTIVATION AND REINFECTION
Sultan Tousif et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?
Anastasia Koch et al.
EMERGING MICROBES & INFECTIONS (2014)
Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease
Matthieu Perreau et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
Michele D. Tameris et al.
LANCET (2013)
Identification of a small molecule with activity against drug-resistant and persistent tuberculosis
Feng Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG
Michele Tameris et al.
TUBERCULOSIS (2013)
Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB
Nancy D. Marin et al.
TUBERCULOSIS (2013)
IL-17 cytokines in immunity and inflammation
Wei Jin et al.
EMERGING MICROBES & INFECTIONS (2013)
Protective and Therapeutic Efficacy of Mycobacterium smegmatis Expressing HBHA-hIL12 Fusion Protein against Mycobacterium tuberculosis in Mice
Shanmin Zhao et al.
PLOS ONE (2012)
MDR, XDR, TDR tuberculosis: ominous progression
Zarir F. Udwadia
THORAX (2012)
CD8+CD44hi but not CD4+CD44hi memory T cells mediate potent graft antilymphoma activity without GVHD
Suparna Dutt et al.
BLOOD (2011)
Autophagy in the immune response to tuberculosis: clinical perspectives
C. Ni Cheallaigh et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Promiscuous Peptide of 16 kDa Antigen Linked to Pam2Cys Protects Against Mycobacterium tuberculosis by Evoking Enduring Memory T-Cell Response
Uthaman Gowthaman et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
A multistage tuberculosis vaccine that confers efficient protection before and after exposure
Claus Aagaard et al.
NATURE MEDICINE (2011)
Co-Administration of IL-1+IL-6+TNF-α with Mycobacterium tuberculosis Infected Macrophages Vaccine Induces Better Protective T Cell Memory than BCG
Vijender Singh et al.
PLOS ONE (2011)
Differentiation of Effector CD4 T Cell Populations
Jinfang Zhu et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Antituberculosis drugs: Drug interactions, adverse effects, and use in special situations. Part 1: First-line drugs
Marcos Abdo Arbex et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2010)
Physiological Numbers of CD4+ T Cells Generate Weak Recall Responses Following Influenza Virus Challenge
Paul G. Thomas et al.
JOURNAL OF IMMUNOLOGY (2010)
Coadministration of Interleukins 7 and 15 with Bacille Calmette-Guerin Mounts Enduring T Cell Memory Response against Mycobacterium tuberculosis
Vijender Singh et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors
Clifford V. Harding et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Cell-Mediated Immune Responses in Tuberculosis
Andrea M. Cooper
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Human Th17 cells in infection and autoimmunity
Federica Sallusto et al.
MICROBES AND INFECTION (2009)
IL-23 and IL-17 in tuberculosis
Shabaana A. Khader et al.
CYTOKINE (2008)
Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice
Emily K. Forbes et al.
JOURNAL OF IMMUNOLOGY (2008)
The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis
Steven C. Derrick et al.
VACCINE (2008)
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge
Shabaana A. Khader et al.
NATURE IMMUNOLOGY (2007)
Human CD4+ T cells lyse target cells via Granzyme/Perforin upon circumvention of MHU class II restriction by an antibody-like immunoreceptor
Andreas Hombach et al.
JOURNAL OF IMMUNOLOGY (2006)
Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patient's for tuberculosis
Banu Eris Gulbay et al.
RESPIRATORY MEDICINE (2006)
Tuberculosis recurrence and mortality after successful treatment:: Impact of drug resistance
Helen Cox et al.
PLOS MEDICINE (2006)
Cytotoxic CD4+ T cells in viral hepatitis
N. Aslan et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis
SJ Ha et al.
GENE THERAPY (2005)
CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions
L Ohl et al.
IMMUNITY (2004)
Potent role of vaccines prepared from macrophages infected with live bacteria in protection against Mycobacterium tuberculosis and Salmonella typhimurium infections
N Sharma et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Review: Multidrug-resistant tuberculosis: public health challenges
RJ Coker
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2004)
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses
DC Jackson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Long-term efficacy of BCG vaccine in American Indians and Alaska natives - A 60-year follow-up study
NE Aronson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis
D Yee et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Erasing the world's slow stain: Strategies to beat muttidrug-resistant tuberculosis
C Dye et al.
SCIENCE (2002)
Structural mechanism for rifampicin inhibition of bacterial RNA polymerase
EA Campbell et al.
CELL (2001)
Augmentation of apoptosis and Interferon-γ production at sites of active mycobacterium tuberculosis infection in human tuberculosis
CS Hirsch et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Action mechanism of antitubercular isoniazid - Activation mycobacterium tuberculosis KatG, isolation, and characterization of InhA inhibitor
BF Lei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
